The Paradigm Biopharmaceuticals Ltd (ASX: PAR) share price is having a difficult day.
In afternoon trade, the biotechnology companyâs shares are down 12% to $1.48.
This makes the Paradigm share price one of the worst performers on the All Ordinaries index today.
Why is the Paradigm share price sinking?
Investors have been hitting the sell button on Tuesday after Paradigm announced the surprise exit of its CEO and managing director, Marco Polizzi.
According to the release, Mr Polizzi has stepped down from his role immediately and will cease employment with the company on 20 February.
Paradigm only announced the appointment of Polizzi at the end of May, with the experienced pharmaceutical industry executive commencing in the role on 1 July. At the time, the company hyped up his appointment, describing him as “a CEO with the skills to fully unlock the commercial value of the company.”
No reason was given for the CEOâs exit after just a few months with the company. Nor did Polizzi leave a parting comment, which is never a good look and could potentially be an indication of boardroom tensions.
What now?
The Paradigm board has acted quickly and appointed the companyâs founder and non-executive chairman Paul Rennie as its new leader. He said:
I am pleased to advise that the personal circumstances that originally required my stepping down from the Managing Director role in 2021, have now been successfully resolved. I look forward to working closely again with the Paradigm executive team and the Board in continuing our journey together.
Following todayâs decline, the Paradigm share price has now lost almost a third of its value over the last 12 months.
The post Why is this ASX All Ords biotech share crashing 12% today? appeared first on The Motley Fool Australia.
Wondering where you should invest $1,000 right now?
When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for over ten years has provided thousands of paying members with stock picks that have doubled, tripled or even more.* Scott just revealed what he believes could be the “five best ASX stocks” for investors to buy right now. These stocks are trading at near dirt-cheap prices and Scott thinks they could be great buys right now
See The 5 Stocks
*Returns as of November 1 2022
(function() {
function setButtonColorDefaults(param, property, defaultValue) {
if( !param || !param.includes(‘#’)) {
var button = document.getElementsByClassName(“pitch-snippet”)[0].getElementsByClassName(“pitch-button”)[0];
button.style[property] = defaultValue;
}
}
setButtonColorDefaults(“#0095C8”, ‘background’, ‘#5FA85D’);
setButtonColorDefaults(“#0095C8”, ‘border-color’, ‘#43A24A’);
setButtonColorDefaults(“#fff”, ‘color’, ‘#fff’);
})()
More reading
- Why is the Polynovo share price on ice today?
- Guess which ASX gold share just soared 100% on a ‘bonanza-grade’ discovery
- Goldman Sachs gives its verdict on the Altium share price
- Here are all the ASX shares I’ve been buying in 2022
- 11 ASX shares that make Abrdn’s World Cup team
Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.
from The Motley Fool Australia https://ift.tt/t2pbrTB
Leave a Reply